end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndOtherAccruedLiabilitiesCurrent,AccountsPayableCurrent,AccountsReceivableNetCurrent,AccruedIncomeTaxesCurrent,AccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,Cash,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashEquivalentsAtCarryingValue,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,ContractWithCustomerLiability,ConversionOfStockAmountConverted1,CurrentFederalStateAndLocalTaxExpenseBenefit,CurrentForeignTaxExpenseBenefit,DeferredIncomeCurrent,DeferredIncomeNoncurrent,DeferredIncomeTaxLiabilities,DeferredOfferingCosts,DeferredTaxAssetsGross,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesPrepaidExpenses,DefinedBenefitPlanContributionsByEmployer,DefinedContributionPlanEmployerMatchingContributionPercent,DepreciationAndAmortization,DerivativeAssets,DividendsPreferredStock,EarningsPerShareBasic,EarningsPerShareBasicAndDiluted,EarningsPerShareDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent,EffectOfExchangeRateOnCashAndCashEquivalents,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease,FairValueNetAssetLiability,FinancialInstrumentsOwnedAtFairValue,GeneralAndAdministrativeExpense,GrantsReceivableCurrent,ImpairmentOfLongLivedAssetsHeldForUse,IncomeLossFromContinuingOperations,IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign,IncomeTaxExpenseBenefit,IncomeTaxesPaidNet,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccruedIncomeTaxesPayable,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInContractWithCustomerLiability,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,IncrementalCommonSharesAttributableToShareBasedPaymentArrangements,InterestPaidNet,LandSubjectToGroundLeases,LeaseAndRentalExpense,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,NumberOfOperatingSegments,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseWeightedAverageDiscountRatePercent,OperatingLossCarryforwards,OtherAccruedLiabilitiesCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax,OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax,OtherLiabilitiesNoncurrent,OtherNonoperatingIncomeExpense,PaymentsOfStockIssuanceCosts,PaymentsToAcquireOtherProductiveAssets,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockAccretionOfRedemptionDiscount,PreferredStockDividendRatePercentage,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromRepaymentsOfRelatedPartyDebt,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet,ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred,ResearchAndDevelopmentExpense,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,RevenueFromContractWithCustomerIncludingAssessedTax,Revenues,RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityCarryingAmountAttributableToParent,WeightedAverageNumberOfDilutedSharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,WeightedAverageNumberOfSharesOutstandingBasic,DeferredIncomeTaxExpenseBenefit,DeferredRevenue,DeferredTaxAssetsOperatingLossCarryforwardsDomestic,DeferredTaxAssetsTaxCreditCarryforwardsForeign,DeferredTaxLiabilities,DeferredTaxLiabilitiesOtherFiniteLivedAssets,EffectiveIncomeTaxRateReconciliationTaxExemptIncome,IncomeTaxReceivable,IncreaseDecreaseInDeferredRevenue,LiabilityForUncertainTaxPositionsCurrent,PreferredStockValue,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,ValuationAllowanceDeferredTaxAssetChangeInAmount
2020-06-30,2020-09-01,10-Q,"iTeos Therapeutics, Inc.",ITOS,CIK0001808865,USD,3360000.0,2656000.0,,,3360000.0,25000.0,2302000.0,-296000.0,687000.0,350000.0,350000.0,,145211000.0,140395000.0,136870000.0,,136993000.0,,,,0.001,90000000.0,388415.0,388415.0,1000.0,-6957000.0,,,,,1500000.0,5883000.0,,1700000.0,,,,,,,,,,,100000.0,,106000.0,,-29.49,,,,,,,,0.0,,,0.0,,2394000.0,133000.0,,,,-7252000.0,,-50000.0,,,,,,,,,,,200000.0,918000.0,,523000.0,,,6000.0,122000.0,267000.0,,12161000.0,145211000.0,7516000.0,,,,-7202000.0,-10302000.0,,8531000.0,-8531000.0,,,,,,,,119000.0,270000.0,245000.0,245000.0,484000.0,12000.0,,,,,,,,,,3180000.0,,,,,,3553000.0,1251000.0,,,6137000.0,123000.0,-48314000.0,,,,,,0.92,,,0.0045,,,716304.0,5.27,,,,,5938000.0,3323378.0,4.54,,,,,,,,1203000.0,,-47922000.0,,,,205000.0,,,349290.0,,,,,,,,,,,,,,,,
2020-09-30,2020-11-12,10-Q,"iTeos Therapeutics, Inc.",ITOS,CIK0001808865,USD,6054000.0,2409000.0,,,6054000.0,25000.0,2440000.0,97000.0,394488000.0,1714000.0,1714000.0,,350944000.0,345734000.0,,339981000.0,340107000.0,,319680000.0,,0.001,150000000.0,35044758.0,35044758.0,35000.0,-10287000.0,,,,,1862000.0,5883000.0,,,,,,,,,,,,,100000.0,,36000.0,-0.48,-0.48,-0.48,-0.001,,,,,,0.0,,,,319680000.0,4799000.0,133000.0,,-11647000.0,-12001000.0,-10688000.0,1313000.0,-8000.0,,,,,,,,,,,100000.0,992000.0,,593000.0,,22000.0,54000.0,173000.0,150000.0,,15318000.0,350944000.0,10325000.0,,,,-10680000.0,-11647000.0,,13525000.0,-13525000.0,,,,,,,,57000.0,261000.0,393000.0,393000.0,505000.0,265000.0,19000000.0,,,,,0.001,10000000.0,0.0,0.0,3262000.0,,,,,,3727000.0,1287000.0,,,8726000.0,126000.0,-58994000.0,,,,,,0.92,,,0.0036,,,747745.0,5.11,,,,,71284000.0,4370466.0,8.36,,,,,,,,14629000.0,,335626000.0,,181903000.0,210699000.0,450000.0,,24349222.0,24349222.0,24349222.0,,,,,,,,,,,,,,,
2020-12-31,2021-03-24,10-K,"iTeos Therapeutics, Inc.",ITOS,CIK0001808865,USD,7486000.0,3026000.0,,,7486000.0,37000.0,2662000.0,617000.0,396443000.0,4292000.0,4292000.0,4552396.0,344558000.0,339544000.0,,336326000.0,336454000.0,316464000.0,314636000.0,7591618.0,0.001,150000000.0,35044758.0,35044758.0,35000.0,-37192000.0,,181903000.0,-60000.0,3000.0,4486000.0,5883000.0,467000.0,,32496000.0,467.0,25206000.0,313000.0,6219000.0,758000.0,32029000.0,445000.0,167000000.0,0.05,535000.0,0.0,249000.0,-2.88,-2.88,-2.88,0.002,0.21,0.008,0.009,1678000.0,0.0,0.0,1265000.0,1265000.0,,314636000.0,15340000.0,133000.0,0.0,-43402000.0,-31184000.0,-38090000.0,-6906000.0,-57000.0,108000.0,1677000.0,,2759000.0,0.0,,-1927000.0,,,,600000.0,3592000.0,1369000.0,667000.0,318000.0,349000.0,385000.0,504000.0,,,21361000.0,344558000.0,14998000.0,340339000.0,-377000.0,-25176000.0,-38033000.0,-43402000.0,1.0,45240000.0,-45240000.0,,,,,0.0,,29000000.0,229000.0,248000.0,841000.0,841000.0,480000.0,-48000.0,332000.0,21000.0,356000.0,5120000.0,,0.001,0.0,0.0,0.0,2893000.0,213660000.0,655000.0,4046000.0,,-38033000.0,4014000.0,1352000.0,,1300000.0,29900000.0,128000.0,-73898000.0,,,,4292000.0,0.0,,1.02,0.9,,0.0135,0.0036,861388.0,4.93,3100000.0,102863.0,3504715.0,7.75,112412000.0,4552396.0,9.13,112412000.0,4552396.0,9.13,2.77,7.18,10.43,0.25,24889000.0,800000.0,323197000.0,236459.0,181903000.0,210612000.0,655000.0,,15080266.0,15080266.0,15080266.0,0.0,,,6219000.0,0.0,0.0,,0.0,1788000.0,0.0,0.0,125358000.0,0.0,,
2021-03-31,2021-05-13,10-Q,"iTeos Therapeutics, Inc.",ITOS,CIK0001808865,USD,5314000.0,5300000.0,,,5314000.0,40000.0,2661000.0,312000.0,399694000.0,2584000.0,2584000.0,5022940.0,332889000.0,324919000.0,,321385000.0,321523000.0,-14931000.0,306446000.0,,0.001,150000000.0,35100999.0,35100999.0,35000.0,-13839000.0,,,,,666000.0,5642000.0,,,,,,,,,,,,,126000.0,,,,-0.39,,,,,,-717000.0,,0.0,,,,306446000.0,7046000.0,1241000.0,,,,,,,,2348000.0,,-2115000.0,-3740000.0,,-493000.0,,,1577.0,200000.0,3668000.0,,571000.0,,351000.0,418000.0,452000.0,562000.0,615000.0,20280000.0,332889000.0,11830000.0,667000.0,-91000.0,-14790000.0,-13534000.0,-13534000.0,,18689000.0,-18689000.0,3053000.0,550000.0,2503000.0,179000.0,3046000.0,0.048,,37000.0,283000.0,-305000.0,-305000.0,305000.0,240000.0,,3000.0,88000.0,,,0.001,10000000.0,0.0,0.0,2293000.0,,667000.0,,,-13534000.0,4011000.0,1350000.0,1200000.0,,11643000.0,138000.0,-87432000.0,,,3206000.0,2584000.0,,,1.0,0.99,,0.0071,0.0042,891880.0,4.39,,2415.0,529200.0,31.98,109086000.0,5022940.0,12.46,,,,11.85,4.24,41.05,,26571000.0,,312609000.0,56241.0,,,667000.0,,,35086662.0,,,,,,,,,,,,,,,,
2021-06-30,2021-08-11,10-Q,"iTeos Therapeutics, Inc.",ITOS,CIK0001808865,USD,7570000.0,11661000.0,,,7570000.0,25000.0,2810000.0,238000.0,403116000.0,3227000.0,3227000.0,,318685000.0,309768000.0,,302933000.0,303072000.0,,286752000.0,667931.0,0.001,150000000.0,35148110.0,35148110.0,35000.0,-26533000.0,,,,,977000.0,5693000.0,,,,,,,,,,,,,200000.0,,,,-0.75,,,,,,,,0.0,,,,286752000.0,15101000.0,4232000.0,,,,-26459000.0,,,,,,,,,,,,1577.0,100000.0,3666000.0,,592000.0,,421000.0,464000.0,480000.0,370000.0,610000.0,29187000.0,318685000.0,20763000.0,,,,-26459000.0,-26459000.0,,29339000.0,-29339000.0,3056000.0,555000.0,2501000.0,189000.0,3048000.0,0.0482,,34000.0,412000.0,-74000.0,-74000.0,230000.0,60000.0,,,,,,0.001,10000000.0,0.0,0.0,2603000.0,,,,,,4831000.0,2021000.0,,,14238000.0,139000.0,-113891000.0,,,110000.0,,,,0.99,0.94,,0.009,0.0084,1469512.0,5.46,,,,,74160000.0,5429419.0,13.7,,,,,,,,29794000.0,,289498000.0,,,,195000.0,,,35119952.0,,,,,,,,,,,,,,,,
2021-09-30,2021-11-10,10-Q,"iTeos Therapeutics, Inc.",ITOS,CIK0001808865,USD,12189000.0,4707000.0,304000.0,2771000.0,12189000.0,25000.0,2904000.0,8754000.0,407499000.0,3942000.0,3942000.0,,922379000.0,914137000.0,,899767000.0,899904000.0,,229035000.0,,0.001,150000000.0,35257464.0,35257464.0,35000.0,78158000.0,520729000.0,,,,522075000.0,5572000.0,,,,,,,,,,,,,200000.0,,,1.98,,1.86,0.038,,,,,,0.0,,,,229035000.0,8761000.0,4891000.0,,69642000.0,-5466000.0,72413000.0,77879000.0,2771000.0,,,,,,,,2285093.0,,1577.0,200000.0,3414000.0,,579000.0,,402000.0,447000.0,468000.0,226000.0,545000.0,550340000.0,922379000.0,542228000.0,,,,69642000.0,69642000.0,,24863000.0,79408000.0,2869000.0,486000.0,2383000.0,191000.0,2859000.0,0.0486,,41000.0,273000.0,8516000.0,8516000.0,181000.0,-8484000.0,,,,,,0.001,10000000.0,0.0,0.0,8940000.0,,,,,,5025000.0,2121000.0,,,16102000.0,137000.0,-44249000.0,104271000.0,104271000.0,6000.0,,,,0.94,0.92,,0.0089,0.0066,1854930.0,7.6,,,,,78236000.0,5388809.0,14.0,,,,,,,,35949000.0,,372039000.0,,,,441000.0,,37482089.0,,35196995.0,,,,,,,,,,,,,,,
